BioSpace News Archive

Rocket Pharmaceuticals, Inc. announces Investigational Medicinal Product Dossier (IMPD) clearance from the Spanish Agency for Medicines and Health Products (AEMPS) for RP-L301.

Forbius announces presentations highlighting AVID200’s immuno-oncology mode of action at the Fifth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (CICON)

GenScript®, the world’s leading gene synthesis provider, today announced that it will provide research support to Harvard University scientist George Church, PhD, for his contributions to the Ultra-safe Cell project, the first grand scale community-wide initiative being undertaken by Genome Project-write and The Center for Excellence in Engineering Biology

To the benefit of millions of people living with uncontrolled psoriasis worldwide, a global consortium of more than 100 physician leaders in dermatology led by the International Psoriasis Council (IPC) has developed a simplified method used to classify psoriasis severity and determine the appropriate course of treatment.

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will host an investor and analyst event on Friday, October 4, 2019 from 8:00 a.m. to 11:30 a.m. ET in New York City, entitled “A New Chapter in PI3Kδ Inhibition to Treat B-cell Malignancies.”

Masimo announced that in a study published in Injury, researchers used Masimo SpHb® – noninvasive, continuous hemoglobin monitoring – to investigate possible delays in the detection of perioperative anemia assessed using invasive, intermittent laboratory hemoglobin values in elderly patients undergoing hip fracture surgery.

Coinciding with its participation in Climate Week and the United Nations Climate Action Summit, 3M is acting on climate change through a new partnership with Clean Air Asia.

IRLAB announced that Prof. Per Svenningsson, on behalf of IRLAB, will be presenting a poster titled “A phase IIa trial studying the safety and tolerability of IRL752 in patients with Parkinson’s disease dementia” at the 2019 International Congress of Parkinson’s Disease and Movement Disorders in Nice, France.

Baylis Medical announced the successful first MitraClip™ procedure performed using the VersaCross™ Transseptal Solution.

Eli Lilly and Company announced data from a number of studies across the company’s oncology product portfolio will be presented at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, September 27 - October 1, 2019.